Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer.
Luvián-Morales J, Flores-Cisneros L, Jiménez-Lima R, Alarcón-Barrios S, Salazar-Mendoza J, Castro-Eguiluz D, Cetina-Pérez L, Oñate-Ocaña LF. Luvián-Morales J, et al. Among authors: jimenez lima r. Int J Gynecol Cancer. 2021 Sep;31(9):1228-1235. doi: 10.1136/ijgc-2021-002720. Epub 2021 Aug 5. Int J Gynecol Cancer. 2021. PMID: 34353855
Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities.
Brau-Figueroa H, Arango-Bravo E, Castro-Eguiluz D, Galicia-Carmona T, Lugo-Alferez LA, Cruz-Bautista I, Jiménez-Lima R, Cetina-Pérez L. Brau-Figueroa H, et al. Among authors: jimenez lima r. Cancer Res Treat. 2022 Apr;54(2):554-562. doi: 10.4143/crt.2021.375. Epub 2021 Aug 10. Cancer Res Treat. 2022. PMID: 34384015 Free PMC article.
Epidemiological Profile, Gastrointestinal Toxicity, and Treatment of Pelvic Cancers in Patients Managed with Radiotherapy to the Abdominal Pelvic Area.
Cetina-Pérez L, Serrano-Olvera A, Flores-Cisneros L, Jiménez-Lima R, Alvarado-Silva C, Díaz-Romero MDC, Morales-Vásquez F, Muñoz-González DE, Mota-García A, Chávez-Fierro OA, Jaramillo-Manzur SC, de la Garza-Salazar J, Castro-Eguiluz D, Meneses-García A. Cetina-Pérez L, et al. Rev Invest Clin. 2018;70(3):112-116. doi: 10.24875/RIC.18002528. Rev Invest Clin. 2018. PMID: 29943771 Free article. Review.
Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients.
Cetina L, González-Enciso A, Cantú D, Coronel J, Pérez-Montiel D, Hinojosa J, Serrano A, Rivera L, Poitevin A, Mota A, Trejo E, Montalvo G, Muñoz D, Robles-Flores J, de la Garza J, Chanona J, Jiménez-Lima R, Wegman T, Dueñas-González A. Cetina L, et al. Ann Oncol. 2013 Aug;24(8):2043-7. doi: 10.1093/annonc/mdt142. Epub 2013 Apr 21. Ann Oncol. 2013. PMID: 23609186 Free article. Clinical Trial.
A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.
Cetina L, Crombet T, Jiménez-Lima R, Zapata S, Ramos M, Avila S, Coronel J, Charco E, Bojalil R, Astudillo H, Bazán B, Dueñas-González A. Cetina L, et al. Cancer Biol Ther. 2015;16(5):684-9. doi: 10.1080/15384047.2015.1026483. Cancer Biol Ther. 2015. PMID: 25802932 Free PMC article.
IMMUNOTHERAPY TREATMENT AGAINST CERVICAL CANCER.
Jiménez-Lima R, Arango-Bravo E, Galicia-Carmona T, Lino-Silva LS, Trejo-Durán GE, Alvarado-Silva C, Castañeda-Renderos OH, Vanoye-Carlo EG, Torre CF, Dueñas-González A, Cetina-Pérez L. Jiménez-Lima R, et al. Rev Invest Clin. 2020;72(4):231-238. doi: 10.24875/RIC.20000060. Rev Invest Clin. 2020. PMID: 33064705 Free article. Review.
IMMUNOLOGY OF CERVICAL CANCER.
Manzo-Merino J, Del-Toro-Arreola S, Rocha-Zavaleta L, Peralta-Zaragoza Ó, Jiménez-Lima R, Madrid-Marina V. Manzo-Merino J, et al. Among authors: jimenez lima r. Rev Invest Clin. 2020;72(4):188-197. doi: 10.24875/RIC.20000057. Rev Invest Clin. 2020. PMID: 33064686 Free article. Review.
13 results